Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Autoimmune Hemolytic Anemia”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738822
What this trial is testing

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Who this might be right for
Immune Thrombocytopenia (ITP)Warm Autoimmune Hemolytic Anemia (WAIHA)
Cullinan Therapeutics Inc. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04398459
What this trial is testing

The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Who this might be right for
Refractory/Relapsed Autoimmune Hemolytic Anemia
Institute of Hematology & Blood Diseases Hospital, China 18
Early research (Phase 1)Not Yet RecruitingNCT07287930
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 13
Early research (Phase 1)Not Yet RecruitingNCT06770504
What this trial is testing

YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic AnemiaAnti-CD19 STAR T-cell TherapyFailure ≥3 Lines of Therapies
Institute of Hematology & Blood Diseases Hospital, China 7
Testing effectiveness (Phase 2)Looking for participantsNCT07549698
What this trial is testing

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

Who this might be right for
Warm Autoimmune Hemolytic Anemia (WAIHA)ITP - Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia+1 more
CRISPR Therapeutics AG 60
Testing effectiveness (Phase 2)Study completedNCT04083014
What this trial is testing

Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic AnemiaAutoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
Peking Union Medical College Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT07175493
What this trial is testing

CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia+1 more
Keymed Biosciences Co.Ltd 158
Not applicableNot Yet RecruitingNCT06847607
What this trial is testing

Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic Anemia
Bing Han 20
Early research (Phase 1)Not Yet RecruitingNCT07453836
What this trial is testing

Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 13
Early research (Phase 1)Ended earlyNCT05676697
What this trial is testing

PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy

Who this might be right for
Autoimmune Hemolytic AnemiaFailure of Two Rounds of Treatment
Institute of Hematology & Blood Diseases Hospital, China 4
Very early researchLooking for participantsNCT07205315
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia (B-ALL)Chronic Lymphocytic Leukemia (CLL)B-cell Non-Hodgkin's Lymphoma (B-NHL)+1 more
Grit Biotechnology 28
Early research (Phase 1)Study completedNCT07075484
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 7
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT07453368
What this trial is testing

Orelabrutinib in the Treatment of Relapsed/Refractory AIHA

Who this might be right for
Autoimmune Hemolytic Anemia (AIHA)
Peking Union Medical College Hospital 50
Not applicableNot Yet RecruitingNCT07149818
What this trial is testing

A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital 22
Testing effectiveness (Phase 2)UnknownNCT05922839
What this trial is testing

Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Chen Miao 22
Very early researchNot Yet RecruitingNCT07689604
What this trial is testing

META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia (AIHA)
Institute of Hematology & Blood Diseases Hospital, China 18
Early research (Phase 1)Not Yet RecruitingNCT07816341
What this trial is testing

Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Study completedNCT05004259
What this trial is testing

The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia

Who this might be right for
Hemolytic Anemia
Dartmouth-Hitchcock Medical Center 2
Testing effectiveness (Phase 2)UnknownNCT06021977
What this trial is testing

The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Who this might be right for
Refractory/Relapsed Autoimmune Hemolytic Anemia
Institute of Hematology & Blood Diseases Hospital, China 33
Next Page